Purchase Order 75D30122P13729
Award Date
8/31/22
Potential Completion Date
8/31/22
Potential Value
$48K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $101,280.02, was awarded by the Centers for Disease Control and Prevention (CDC) for the provision of a reagent kit. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received prime federal contract awards from agencies such as the National Institutes of Health (NIH), U.S....
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $75,262.76, is for the supply of MiSeq Reagent Kits to support the agency's genomic sequencing and analysis capabilities. This award does not have a set-aside designation. Illumina has a history of providing sequencing systems, reagents, and related services to...
This federal contract award to Illumina, Inc. is for the procurement of a MiSeq System, a genetic sequencing platform and associated consumables and services. The $93,529 firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract does not have a set-aside designation. Illumina is a leading manufacturer of advanced genetic sequencing instruments, reagents, and bioinformatics software. The company has been awarded multiple federal...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $75,775.80 contract is for the provision of Illumina MiSeq reagents to support the agency's genomic sequencing and analysis needs. The contract has no set-aside designation. Illumina has previously provided a range of sequencing systems, consumables, and services to support...
This $96,401.25 firm fixed price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract is for the provision of a MiSeq DNA sequencing system and does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the NIH, USDA, VA, and others for sequencing systems, reagents, and...
This is a firm fixed price purchase order awarded by the U.S. Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for a MiSeq System. The $131,966.00 contract has a period of performance ending on July 31, 2016. Illumina has provided sequencing systems and services to various federal agencies in the past, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to...
This is a $80,453.34 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract is for the provision of reagent products to support the CDC's genomic sequencing and analysis work. Illumina has a history of providing sequencing systems, reagents, and related services to federal agencies like the NIH, USDA, and VA for research and diagnostics. This award does not have...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of an Illumina MiSeq genomic sequencing system, with a ceiling value of $135,435.37 and a performance period ending on November 30, 2015. The order does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $241,046.40 firm fixed-price purchase order to Illumina, Inc. to provide reagents and supplies. The award has no set-aside designation. Illumina is a manufacturer and provider of genetic sequencing instruments and analytical products. This award aligns with Illumina's past prime federal contracts to support genomic sequencing and analysis for various government agencies including the CDC,...
This firm fixed-price contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The $158,939.56 award is for the provision of Illumina's MiSeq sequencing platform and related consumables to support comprehensive genomic analysis work. This contract is not set aside for any small business categories. Illumina has previously received prime contract awards from...